 |
|
|
|
|
|
|
|
 |
Results for 'Millennium Pharmaceuticals Inc - Deals and Alliances Report' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Millennium Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
100 % |
Millennium Pharmaceuticals Inc -Detailed Product Pipeline
|
February 2008 |
£375 |
37 % |
Pharmaceutical Strategic Alliances
Maximizing returns from collaborative development and commercialization
|
September 2006 |
£1495 |
35 % |
Pharmaceutical Licensing Strategies
Best practices in deal-making, valuations and strategic management
|
June 2006 |
£1495 |
25.2 % |
The Biotechnology Market Outlook
Growth opportunities and effective strategies for licensing and collaborations
|
January 2005 |
£1495 |
19.95 % |
Biomarkers & Related Tests for Molecular Diagnostics & Pharma/ Biotech R&D
Companies, Products & Worldwide Market, 2004-2009
|
July 2005 |
£940 |
13.3 % |
Impact of Pharmacogenomics on Public Healthcare Policy
Educating Patients, Payors and Healthcare Providers
|
March 2008 |
£1995 |
11.9 % |
Johnson & Johnson
PharmaVitae Profile
|
July 2008 |
£2995 |
11.55 % |
The Worldwide Market for Cancer Diagnostics
3rd Edition
|
March 2008 |
£2015 |
10.5 % |
World Market for Prescription Orthopedic Drugs, The
|
October 2006 |
£1765 |
10.5 % |
The Impact of the Phase III Pipeline
Future Projections and Market Disruptions
|
March 2006 |
£1765 |
10.5 % |
World Market for Prescription Gastrointestinal Drugs, The
|
July 2006 |
£1765 |
10.5 % |
Emerging Cancer Vaccine Market, The
2nd Edition
|
November 2006 |
£1765 |
10.5 % |
HIV: A Strategic Analysis of Therapeutic and Testing Markets
|
March 2006 |
£1765 |
10.5 % |
World Market for Prescription Respiratory Drugs, The
|
October 2006 |
£1765 |
10.5 % |
Worldwide Market for In Vitro Diagnostic Tests
5th Edition
|
April 2006 |
£1970 |
10.5 % |
World Market for Prescription Generic Drugs; The
5th Edition
|
April 2006 |
£1765 |
10.5 % |
World Market for Pain Management Drugs and Devices
2nd Edition
|
December 2006 |
£1765 |
10.5 % |
Immunomodulators in Cancer Therapy
Emerging Products and Markets
|
August 2004 |
£1765 |
10.5 % |
Pharmaceutical Outsourcing Opportunities Post Launch
Contract Manufacturing, and Sales and Marketing,2nd Edition
|
September 2006 |
£1970 |
10.5 % |
Genomics World Markets
|
May 2008 |
£1715 |
10.5 % |
World Market for Respiratory Equipment; The
|
November 2005 |
£1765 |
10.5 % |
World Market for Psychotherapeutic Drugs, The
|
January 2007 |
£1765 |
10.5 % |
Global Market for Adjunctive Therapies in Cancer, The
2nd Edition
|
April 2006 |
£1765 |
10.5 % |
Worldwide Market for Pediatric Drugs; The
2nd Edition
|
November 2005 |
£1765 |
10.5 % |
Medical and Biological Sensors and Sensor Systems
Markets, Applications, and Competitors Worldwide, 2nd Edition
|
May 2006 |
£1765 |
10.5 % |
Commercial Opportunities from Biomarkers
Transforming drug discovery, clinical development and molecular diagnostic
|
May 2006 |
£1495 |
9.45 % |
World Biotech Market 2005, The
|
June 2005 |
£4999 |
7.7 % |
Apoptosis
|
January 2008 |
£1440 |
7.35 % |
Bioinformatics Markets
Strategies, Business Models and Trends for the Future
|
June 2006 |
£1690 |
7.35 % |
Bausch & Lomb Incorporated Medical Equipment Company Report
Medical Device Company Analysis Covering Key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis
|
May 2008 |
£505 |
7 % |
Online Pharmaceutical Industry, 2006-2011, The
|
July 2006 |
£1499 |
6.65 % |
Executive Guide to Molecular Imaging; The
|
April 2005 |
£395 |
6.3 % |
Bausch & Lomb Incorporated Product Pipeline Analysis
|
August 2008 |
£400 |
5.25 % |
In Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
4.2 % |
In-Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
4.2 % |
|
|
|
|
